The Health Care Resource Directory

Modify a Normal Listing



Advanced


Top : Modify a Normal Listing

!!title_without_link!!
US-based clinical-stage biotech developing nanobody therapeutics for aggressive cancers. Lead candidate PHP53-nb reactivates mutant p53 to trigger apoptosis in TNBC and other p53-driven tumors. HQ: Southlake, Texas.
https://phpbiotech.com/
From: Health/Biotech
Current Rating: 0
Number of Votes: 0
Hits: 15
Date: Jul 3, 2026
Modify Password:

Lost your password? Click here to retrieve your password